Patents by Inventor Roland Jurecic

Roland Jurecic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100273862
    Abstract: The present invention provides novel JNK activating phosphatase polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing JNK activating phosphatase polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with JNK activating phosphatase polypeptides.
    Type: Application
    Filed: January 22, 2007
    Publication date: October 28, 2010
    Applicants: Amgen Inc., Baylor College of Medicine
    Inventors: John W. Belmont, Frederick A. Fletcher, Alice J. Chen, Roland Jurecic, Tse-Hua Tan, Guisheng Zhou
  • Patent number: 7195902
    Abstract: The present invention provides novel JNK activating phosphatase polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing JNK activating phosphatase polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with JNK activating phosphatase polypeptides.
    Type: Grant
    Filed: March 18, 2004
    Date of Patent: March 27, 2007
    Assignees: Amgen Corporation, Baylor College of Medicine
    Inventors: John W. Belmont, Frederick A. Fletcher, Alice J. Chen, Roland Jurecic, Tse-Hua Tan, Guisheng Zhou
  • Patent number: 6900043
    Abstract: The present invention provides novel JNK activating phosphatase polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing JNK activating phosphatase polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with JNK activating phosphatase polypeptides.
    Type: Grant
    Filed: September 20, 2000
    Date of Patent: May 31, 2005
    Assignee: Amgen Inc.
    Inventors: John W. Belmont, Frederick A. Fletcher, Alice J. Chen, Roland Jurecic, Tse-Hua Tan, Guisheng Zhou
  • Patent number: 6872812
    Abstract: The invention is directed to an isolated gene and protein product, designated Hepp, which has a role in mammalian hematopoiesis and neural function, and is further directed to a genetically modified non-human mammal that is homozygous or heterozygous for a disruption in the endogenous Hepp gene.
    Type: Grant
    Filed: February 15, 2002
    Date of Patent: March 29, 2005
    Assignee: University of Miami
    Inventors: Roland Jurecic, Ronald G. Nachtman
  • Publication number: 20050014222
    Abstract: The present invention provides novel JNK activating phosphatase polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing JNK activating phosphatase polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with JNK activating phosphatase polypeptides.
    Type: Application
    Filed: March 18, 2004
    Publication date: January 20, 2005
    Inventors: John Belmont, Frederick Fletcher, Alice Chen, Roland Jurecic, Tse-Hua Tan, Guisheng Zhou
  • Publication number: 20020177214
    Abstract: An isolated gene and protein product, designated Hepp, having a role in mammalian hematopoiesis and neural function, and a genetically modified non-human mammal that is homozygous or heterozygous for a disruption in the endogenous Hepp gene.
    Type: Application
    Filed: February 15, 2002
    Publication date: November 28, 2002
    Inventors: Roland Jurecic, Ronald G. Nachtman